
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Protective effect of traditional Chinese medicine on non-alcoholic fatty liver disease and liver cancer by targeting ferroptosis
Qiongbo Wu, Zihao Chen, Yi Ding, et al.
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 22
Qiongbo Wu, Zihao Chen, Yi Ding, et al.
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 22
Showing 22 citing articles:
Targeting ferroptosis unveils a new era for traditional Chinese medicine: a scientific metrology study
Siyang Cao, Yihao Wei, Yaohang Yue, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 10
Siyang Cao, Yihao Wei, Yaohang Yue, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 10
Salvigenin Suppresses Hepatocellular Carcinoma Glycolysis and Chemoresistance Through Inactivating the PI3K/AKT/GSK-3β Pathway
Hui Shao, Jingyan Chen, Ali Li, et al.
Applied Biochemistry and Biotechnology (2023) Vol. 195, Iss. 8, pp. 5217-5237
Open Access | Times Cited: 17
Hui Shao, Jingyan Chen, Ali Li, et al.
Applied Biochemistry and Biotechnology (2023) Vol. 195, Iss. 8, pp. 5217-5237
Open Access | Times Cited: 17
Ferroptosis in Liver Disease: Natural Active Compounds and Therapeutic Implications
Zhili Wu, Yanru Zhu, Wen‐Chao Liu, et al.
Antioxidants (2024) Vol. 13, Iss. 3, pp. 352-352
Open Access | Times Cited: 5
Zhili Wu, Yanru Zhu, Wen‐Chao Liu, et al.
Antioxidants (2024) Vol. 13, Iss. 3, pp. 352-352
Open Access | Times Cited: 5
JiGuCao capsule formula alleviates metabolic fatty liver disease by regulating the gut–liver axis and lipid metabolism
Wenying Qi, Xu Cao, Yue Chen, et al.
Phytomedicine (2025) Vol. 140, pp. 156559-156559
Open Access
Wenying Qi, Xu Cao, Yue Chen, et al.
Phytomedicine (2025) Vol. 140, pp. 156559-156559
Open Access
NCAPD3-mediated ferroptosis of 2,3,5,4’-Tetrahydroxystilbene-2-O-β-D-glucoside inhibits proliferation in T47D cells
Jianfen Shen, Yulong Zhang, Yan Song, et al.
Frontiers in Pharmacology (2025) Vol. 15
Open Access
Jianfen Shen, Yulong Zhang, Yan Song, et al.
Frontiers in Pharmacology (2025) Vol. 15
Open Access
Bibliometric analysis of ferroptosis: a comprehensive evaluation of its contribution to lung cancer
Feifei Yao, Feng Guo, Chengyi Sun, et al.
Frontiers in Genetics (2025) Vol. 15
Open Access
Feifei Yao, Feng Guo, Chengyi Sun, et al.
Frontiers in Genetics (2025) Vol. 15
Open Access
The Chinese Herbal TiaoGanXiaoZhi Formula Alleviates the Progression of Metabolic‐Associated Fatty Liver Disease by Regulating the Gut Microbiota
Wenying Qi, Xu Cao, Yue Chen, et al.
Portal hypertension & cirrhosis (2025)
Open Access
Wenying Qi, Xu Cao, Yue Chen, et al.
Portal hypertension & cirrhosis (2025)
Open Access
Multi-omics joint analysis: Pachymic acid ameliorated non-alcoholic fatty liver disease by regulating gut microbiota
Guilin Ren, Yiyou Lin, Yilong Fu, et al.
Food Research International (2025), pp. 116178-116178
Closed Access
Guilin Ren, Yiyou Lin, Yilong Fu, et al.
Food Research International (2025), pp. 116178-116178
Closed Access
Cutting edge: ferroptosis in metabolic dysfunction-associated steatotic liver disease (MASLD) pathogenesis and therapy
Amr Ali Mohamed Abdelgawwad El-Sehrawy, Teeba Ammar Rashid, Muhammad Ikram Ullah, et al.
Functional & Integrative Genomics (2025) Vol. 25, Iss. 1
Closed Access
Amr Ali Mohamed Abdelgawwad El-Sehrawy, Teeba Ammar Rashid, Muhammad Ikram Ullah, et al.
Functional & Integrative Genomics (2025) Vol. 25, Iss. 1
Closed Access
Didymin alleviates metabolic dysfunction-associated fatty liver disease (MAFLD) via the stimulation of Sirt1-mediated lipophagy and mitochondrial biogenesis
H. J. Yang, Ying Zou, Jun Chen, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 10
H. J. Yang, Ying Zou, Jun Chen, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 10
Research progress of ferroptosis regulating lipid peroxidation and metabolism in occurrence and development of primary liver cancer
Yu-Jie Shu, B. Lao, Ying-Yang Qiu
World Journal of Gastrointestinal Oncology (2024) Vol. 16, Iss. 6, pp. 2335-2349
Open Access | Times Cited: 2
Yu-Jie Shu, B. Lao, Ying-Yang Qiu
World Journal of Gastrointestinal Oncology (2024) Vol. 16, Iss. 6, pp. 2335-2349
Open Access | Times Cited: 2
GA receptor targeted chitosan oligosaccharide polymer nanoparticles improve non-alcoholic fatty liver disease by inhibiting ferroptosis
Yu Yao, Qi Wang, Xi Huang, et al.
International Journal of Biological Macromolecules (2024) Vol. 278, pp. 134779-134779
Closed Access | Times Cited: 2
Yu Yao, Qi Wang, Xi Huang, et al.
International Journal of Biological Macromolecules (2024) Vol. 278, pp. 134779-134779
Closed Access | Times Cited: 2
Curcumin promotes ferroptosis in hepatocellular carcinoma via upregulation of ACSL4
Yulang Jiang, Dengcheng Hui, Ziyang Pan, et al.
Journal of Cancer Research and Clinical Oncology (2024) Vol. 150, Iss. 9
Open Access | Times Cited: 2
Yulang Jiang, Dengcheng Hui, Ziyang Pan, et al.
Journal of Cancer Research and Clinical Oncology (2024) Vol. 150, Iss. 9
Open Access | Times Cited: 2
Huanglian-Hongqu herb pair improves nonalcoholic fatty liver disease via NF-κB/NLRP3 pathway in mice: network pharmacology, molecular docking and experimental validation
Zheng Wang, Hairong Qiu, Yang Yang, et al.
Hereditas (2024) Vol. 161, Iss. 1
Open Access | Times Cited: 1
Zheng Wang, Hairong Qiu, Yang Yang, et al.
Hereditas (2024) Vol. 161, Iss. 1
Open Access | Times Cited: 1
Naringenin inhibits APAP-induced acute liver injury through activating PPARA-dependent signaling pathway
Jiepei Xu, Jiamin Chen, Jinji Deng, et al.
Experimental Cell Research (2024) Vol. 437, Iss. 2, pp. 114028-114028
Closed Access | Times Cited: 1
Jiepei Xu, Jiamin Chen, Jinji Deng, et al.
Experimental Cell Research (2024) Vol. 437, Iss. 2, pp. 114028-114028
Closed Access | Times Cited: 1
Coptisine-mediated downregulation of E2F7 induces G2/M phase arrest in hepatocellular carcinoma cells through inhibition of E2F4/NFYA/NFYB transcription factors
Hongmei Wang, Zhengcai Ma, Minmin Xu, et al.
Chemico-Biological Interactions (2024) Vol. 397, pp. 111063-111063
Closed Access | Times Cited: 1
Hongmei Wang, Zhengcai Ma, Minmin Xu, et al.
Chemico-Biological Interactions (2024) Vol. 397, pp. 111063-111063
Closed Access | Times Cited: 1
Novel insights into the role of quercetin and kaempferol from Carthamus tinctorius L. in the management of nonalcoholic fatty liver disease via NR1H4-mediated pathways
Wenxiang Wang, Ce Yang, Jing Xia, et al.
International Immunopharmacology (2024) Vol. 143, pp. 113035-113035
Closed Access | Times Cited: 1
Wenxiang Wang, Ce Yang, Jing Xia, et al.
International Immunopharmacology (2024) Vol. 143, pp. 113035-113035
Closed Access | Times Cited: 1
Research on the Protective Effects of Different Chinese Medicine Compounds on Gefitinib-Induced Hepatotoxicity
Xiaoting Yin, Min Li, Yucheng Li
Chinese medicine and natural products (2024) Vol. 04, Iss. 02, pp. e76-e84
Open Access
Xiaoting Yin, Min Li, Yucheng Li
Chinese medicine and natural products (2024) Vol. 04, Iss. 02, pp. e76-e84
Open Access
Progress in the Study of Iron Death Induced in Hepatocellular Carcinoma Cells by Traditional Chinese Medicine and Its Active Ingredients
Raoyan Tan, Gang Xiao, Hui Guo
Journal of Contemporary Medical Practice (2024) Vol. 6, Iss. 7, pp. 48-52
Closed Access
Raoyan Tan, Gang Xiao, Hui Guo
Journal of Contemporary Medical Practice (2024) Vol. 6, Iss. 7, pp. 48-52
Closed Access
Targeting ferroptosis in treating traumatic brain injury: Harnessing the power of traditional Chinese medicine
Zhongjie Sun, X. Peter Zhang, Manrui Li, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 180, pp. 117555-117555
Open Access
Zhongjie Sun, X. Peter Zhang, Manrui Li, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 180, pp. 117555-117555
Open Access
Syzygium aromaticum Extract Mitigates Doxorubicin-Induced Hepatotoxicity in Male Rats
Alaa Muqbil Alsirhani, Amal S. Abu-Almakarem, Maha Abdullah Alwaili, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 23, pp. 12541-12541
Open Access
Alaa Muqbil Alsirhani, Amal S. Abu-Almakarem, Maha Abdullah Alwaili, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 23, pp. 12541-12541
Open Access
Molecular mechanisms of metabolic disease-associated hepatic inflammation in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
Chunye Zhang, Yuxiang Sui, Shuai Liu, et al.
(2023), pp. 246-275
Open Access | Times Cited: 1
Chunye Zhang, Yuxiang Sui, Shuai Liu, et al.
(2023), pp. 246-275
Open Access | Times Cited: 1
The Curative and Preventative Effects of Traditional Chinese Medicine on Ferroptosis of Hepatocellular Carcinoma
Wei Peng, Renyi Yang, Kexiong Li, et al.
Natural Product Communications (2023) Vol. 18, Iss. 12
Open Access | Times Cited: 1
Wei Peng, Renyi Yang, Kexiong Li, et al.
Natural Product Communications (2023) Vol. 18, Iss. 12
Open Access | Times Cited: 1
Linggui Zhugan Decoction Delayed the Progression of NAFLD-HCC by Regulating Fatty Acid Metabolism Through AKT/mTOR/SREBP-1/SCD-1 Signaling Pathway
Lianqun Jia, Liang Kong, Huimin Cao, et al.
(2023)
Closed Access
Lianqun Jia, Liang Kong, Huimin Cao, et al.
(2023)
Closed Access